MediaNewsPublicationsVideosAwareness CampaignsNewsPrintTweet04/19/2022The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first timeMore04/01/2022Study sheds light on why immunodeficiency affects only one identical twinMore02/17/2022Alterations discovered in the assembly chain of proteins in cancer cellsMore01/19/2022Unveiled the epigenetic mechanism by which vitamin D modulates the tolerance of the immune systemMore07/29/2021Discovered a key alteration in the genes involved in the development of Cornelia de Lange syndromeMore07/21/2021CADs: a new family of drugs to fight against acute myeloid leukemiaMore07/14/2021Researchers at the Josep Carreras Institute find a weakness that could be exploited to treat SMARCA4 defective cancersMore05/25/2021Research centers throughout Spain collaborate to deploy the latest genomic analysis technologies and identify therapeutic targets in childhood cancerMore04/15/2021Discovery of epigenetic factors predicting the severity of COVID-19More03/03/2021The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid LeukaemiaMoreFirstPrevious12345678910NextLastWebpage updated 10/16/2019 13:23:15
04/19/2022The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first timeMore
01/19/2022Unveiled the epigenetic mechanism by which vitamin D modulates the tolerance of the immune systemMore
07/29/2021Discovered a key alteration in the genes involved in the development of Cornelia de Lange syndromeMore
07/14/2021Researchers at the Josep Carreras Institute find a weakness that could be exploited to treat SMARCA4 defective cancersMore
05/25/2021Research centers throughout Spain collaborate to deploy the latest genomic analysis technologies and identify therapeutic targets in childhood cancerMore
03/03/2021The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid LeukaemiaMore
José Carreras Leukaemia Foundation